Advertisement

Topics

Immuno Mycologics, Inc. 2003 Company Profile

05:24 EST 11th December 2018 | BioPortfolio

The Company IMMY was founded in 1979 to produce fungal diagnostic products. IMMY then attracted a staff of knowledgable, qualified people who remain dedicated to quality and innovation. The company is located outside Norman, Oklahoma, the home of the University of Oklahoma, and the heartland of the United States.The Purpose The idea behind the founding of IMMY was that mycology was virtually a forgotten area in the clinical laboratory and diagnostic products for the mycoses would greatly benefit patients with mycotic infections. Initially, we concentrated on systemic mycoses (histoplasmosis, blastomycosis, coccidioidomycosis, and cryptococcosis). Subsequently, we have expanded the product line into the opportunistic and more esoteric fungi such as Aspergillus sp., Candida albicans, Paracoccidioides, etc

Location

P.O.Box 1151
Norman
Oklahoma
73070
United States of America

Contact

Phone: 405-288-2383
Fax: 405-288-2228

Email: inof@immy.com


News Articles [302 Associated News Articles listed on BioPortfolio]

Immuno-Oncology Conference 2018

26 - 27 September, London, UK. Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies. SMi's Immuno-Oncology Conference will focus on a few key...

10 Top Immuno-Oncology Companies

One of the most highly anticipated methods to fight cancer is the immuno-oncology (I/O) sector. For investors interested in the field the Investing News Network (INN) has put together a list of top im...

New ASCO/SITC Guidance Addresses Shortcomings of Immuno-Oncology Trial Reporting

The recommendations on Trial Reporting in Immuno-Oncology aim to enchance understanding of efficacy and toxicity outcomes in immuno-oncology trials.

Manipulating microglia

Alector’s $133M series E will enable the immuno-neurology and immuno-oncology company to take five programs into the clinic.

Lilly and NextCure pen immuno-oncology deal

Eli Lilly & Co. and NextCure Inc. partnered to discover and develop new immuno-oncology therapies utilizing NextCure’s FIND-IO (Functional, Integrated, NextCure Discovery in Immuno Oncology) platfor...

GSK Funds a New Startup with Immunometabolic Focus

A new biopharmaceutical company known as Sitryx launched with $30 million in a Series A funding round to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation.

Will BeiGene emerge as the first Chinese immuno-oncology leader?

BeiGene, a Chinese biopharmaceutical company that is keen for its immuno-oncology candidates to compete as cancer treatments alongside those of...Read More... The post Will BeiGene emerge as the first...

CRISPR, MaxCyte expand partnership into immuno-oncology

The companies have entered into a non-exclusive commercial license agreement that will allow CRISPR Therapeutics to deploy MaxCyte’s Flow Electroporation Technology to develop CRISPR/Cas9-based ther...

Drugs and Medications [32 Associated Drugs and Medications listed on BioPortfolio]

Penicillin v potassium [NorthStar Rx LLC]

Penicillin V Potassium Tablets, USP

Eco-clean elite [Ecolab Inc.]

Drug Facts

Boniva [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use BONIVA Tablets safely and effectively. See full prescribing information for BONIVA Tablets. BONIVA® (ibandronate sodium) Tablets Init...

Boniva [Genentech, Inc.]

These highlights do not include all the information needed to use BONIVA Tablets safely and effectively. See full prescribing information for BONIVA Tablets. BONIVA (ibandronate sodium) Tablets Initia...

Bss [Alcon Laboratories, Inc.]

BSS® Sterile Irrigating Solution (balanced salt solution)

PubMed Articles [259 Associated PubMed Articles listed on BioPortfolio]

Point of Care Cryptococcal Antigen Screening: Pipetting Finger-Prick Blood Improves Performance of Immuno-Mycologics Lateral Flow Assay.

Cryptococcal antigen (CrAg) screening at point of care could improve cryptococcal meningitis prevention where laboratory resources are limited. We evaluated the accuracy of Immuno-Mycologics (IMMY, No...

The HIV patient profile in 2013 and 2003: Results from the Greek AMACS cohort.

Combined Antiretroviral therapy (cART) has improved life-expectancy of people living with HIV (PLHIV) but as they age, prevalence of chronic non-AIDS related comorbidities may increase. We study the e...

Challenges in Immuno-Oncology - Possibilities for Optimization.

Immuno-oncology has undoubtedly started a new era in the treatment of malignant diseases. Within a short time immunotherapeutic therapy concepts have become part of the standard therapy for many tumor...

Prevalence of arterial hypertension, diabetes mellitus, and adherence to behavioral measures in the city of São Paulo, Brazil, 2003-2015.

The objective was to compare the estimates for prevalence of diabetes, hypertension, and behavioral measures to control these diseases. Data were analyzed for the adult population from Health Surveys ...

Demonstration of IgG Subclass (IgG1 and IgG3) in Immuno-Related Hemocytopenia.

Immuno-related hemocytopenia (IRH) is defined as idiopathic cytopenia of undetermined significance (ICUS) patients with autoantibodies. In our previous studies, we found that IgG1 levels were increase...

Clinical Trials [1304 Associated Clinical Trials listed on BioPortfolio]

Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia

The purpose of this study is to determine the safety and efficacy of multiple doses of CAT-2003 in patients with severe hypertriglyceridemia either naive or refractory to current therapy. ...

Exposure Chamber Trial With Cat Immunotherapy

The main purpose of this trial is to investigate if any of three different doses of cat hair immunotherapy is safe for treatment of cat allergic patients.

Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)

The purpose of this study is to investigate the effect of NPL-2003 on the symptoms of Obsessive Compulsive Disorder (OCD) in an adolescent population.

Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03

This is a comparative vaccination study of the reactogenicity and immunogenicity of a thiomersal-free formulation of Influsplit SSW® 2002/2003 versus the standard formulation of Influspli...

Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy

We wanted to examine the immunogenicity and safety of a shortened specific immunotherapy in contrast to the standard specific immunotherapy. Therefore, we challenged 12 patients for 14 we...

Companies [566 Associated Companies listed on BioPortfolio]

Immuno Mycologics, Inc. 2003

The Company IMMY was founded in 1979 to produce fungal diagnostic products. IMMY then attracted a staff of knowledgable, qualified people who remain dedicated to quality and innovation. The company i...

Bionor Immuno AS

Bionor Immuno is a multidisciplinary drug discovery company located in Skien, Norway. The major focus of the company is to develop effective peptide based immunotherapies, against infectious diseases ...

Immuno Laboratories

Headquartered in Fort Lauderdale, Florida, Immuno Laboratories is widely recognized as one of the leading food and environmental allergy testing facilities in the world. Since 197...

Immunotech Laboratories, Inc.

Headquartered in Monrovia, CA, Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitati...

SDIX

SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, reta...

More Information about "Immuno Mycologics, Inc. 2003" on BioPortfolio

We have published hundreds of Immuno Mycologics, Inc. 2003 news stories on BioPortfolio along with dozens of Immuno Mycologics, Inc. 2003 Clinical Trials and PubMed Articles about Immuno Mycologics, Inc. 2003 for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immuno Mycologics, Inc. 2003 Companies in our database. You can also find out about relevant Immuno Mycologics, Inc. 2003 Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record